or Try an Advanced Search...

    Treatment Of Parkinson's Disease Stocks List

    Symbol Grade Name % Change
    IKT D Inhibikase Therapeutics, Inc. 29.22
    CCM D Concord Medical Services Holdings Limited ADS 11.46
    NRSNW F NeuroSense Therapeutics Ltd. - warrant 5.66
    NERV F Minerva Neurosciences, Inc 3.83
    ACAD F ACADIA Pharmaceuticals Inc. 1.75
    ITCI D Intra-Cellular Therapies Inc. 1.72
    VYGR D Voyager Therapeutics, Inc. 1.06
    AMRX B Amneal Pharmaceuticals, Inc. 0.28
    TEVA B Teva Pharmaceutical Industries -1.81
    ATHE D Alterity Therapeutics Limited -2.86
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
    Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Parkinson's Disease stocks.

    Symbol Grade Name Weight
    ISRA C Market Vectors Israel ETF 10.02
    EIS C iShares MSCI Israel Capped Investable Market Index Fund 9.21
    IBRN D iShares Neuroscience and Healthcare ETF 7.94
    FBT C First Trust Amex Biotech Index Fund 6.66
    XPH C SPDR S&P Pharmaceuticals ETF 5.66
    View all Treatment Of Parkinson's Disease ETFs...
    Compare ETFs
    Compare ISRA to FBT Compare ISRA to IBRN Compare ISRA to XPH

        Treatment Of Parkinson's Disease Stocks Recent News

        Date Stock Title
        May 15 ACAD Acadia Pharmaceuticals Announces Launch of Magnolia's Guide to Adventuring: A Groundbreaking Documentary Series Aiming to Raise Disease Awareness and Redefine Perceptions of Rett Syndrome
        May 15 TEVA Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
        May 14 TEVA Teva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)
        May 14 TEVA Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
        May 14 VYGR Q1 2024 Voyager Therapeutics Inc Earnings Call
        May 14 TEVA Israel’s Once-Dominant Drugmaker Is Revived by Innovation
        May 14 VYGR Voyager Therapeutics, Inc. (VYGR) Q1 2024 Earnings Call Transcript
        May 14 VYGR Voyager Therapeutics Inc (VYGR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
        May 13 VYGR Voyager Therapeutics up 8% following quarterly beats
        May 13 VYGR Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
        May 13 VYGR Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M
        May 13 VYGR Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
        May 13 TEVA Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock?
        May 12 TEVA These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio?
        May 12 ACAD Cantor picks 14 undervalued biotech stocks worth a second look
        May 11 ACAD Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
        May 10 ACAD ACADIA Pharmaceuticals Q1 2024 Earnings: Solid Growth with New Product Launches
        May 10 ACAD ACADIA Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 9 ACAD Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
        May 9 ACAD ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Care
        Related Stock Lists: Parkinson's Disease Alzheimer's Disease Medicine Drugs Neuroscience Schizophrenia Aging Associated Diseases Amyotrophic Lateral Sclerosis Biopharmaceutical Biotechnology Cancer Dementia Depressive Disorder Huntington's Disease Insomnia Major Depressive Disorder Medication Neurological Disorders Pain Pharmaceutical
        Treatment Of Parkinson's Disease

        Treatment of Parkinson's disease typically involves a combination of medications, lifestyle changes, and therapies. Medications used to treat Parkinson's disease include levodopa, dopamine agonists, MAO-B inhibitors, anticholinergics, and amantadine. Lifestyle changes may include exercise, diet, and stress management. Therapies such as physical therapy, occupational therapy, speech therapy, and cognitive behavioral therapy may also be used to help manage symptoms.

        Browse All Tags